BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu SS, Wu F, Jin YM, Chang WQ, Xu TM. HDAC11: a rising star in epigenetics. Biomed Pharmacother 2020;131:110607. [PMID: 32841898 DOI: 10.1016/j.biopha.2020.110607] [Cited by in Crossref: 13] [Cited by in F6Publishing: 31] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Wei Y, Guo Y, Lv S. Research on the progress of Traditional Chinese medicine components and preparations on histone deacetylase inhibitors - Like effects in the course of disease treatment. J Ethnopharmacol 2022;296:115521. [PMID: 35809757 DOI: 10.1016/j.jep.2022.115521] [Reference Citation Analysis]
2 Feng J, Meng X. Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond. Front Pharmacol 2022;13:946811. [DOI: 10.3389/fphar.2022.946811] [Reference Citation Analysis]
3 Fang Y, Zhao J, Guo X, Dai Y, Zhang H, Yin F, Zhang X, Sun C, Han Z, Wang H, Han Y. Establishment, immunological analysis, and drug prediction of a prognostic signature of ovarian cancer related to histone acetylation. Front Pharmacol 2022;13:947252. [DOI: 10.3389/fphar.2022.947252] [Reference Citation Analysis]
4 Hai R, Yang D, Zheng F, Wang W, Han X, Bode AM, Luo X. The emerging roles of HDACs and their therapeutic implications in cancer. Eur J Pharmacol 2022;931:175216. [PMID: 35988787 DOI: 10.1016/j.ejphar.2022.175216] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Singh T, Kaur P, Singh P, Singh S, Munshi A. Differential molecular mechanistic behavior of HDACs in cancer progression. Med Oncol 2022;39:171. [PMID: 35972597 DOI: 10.1007/s12032-022-01770-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Li R, Wu X, Zhao P, Xue K, Li J. A pan-cancer analysis identifies HDAC11 as an immunological and prognostic biomarker. FASEB J 2022;36:e22326. [PMID: 35657209 DOI: 10.1096/fj.202101742RR] [Reference Citation Analysis]
7 Torres OV. Sex Differences in Psychostimulant Abuse: Implications for Estrogen Receptors and Histone Deacetylases. Genes 2022;13:892. [DOI: 10.3390/genes13050892] [Reference Citation Analysis]
8 Brancolini C, Gagliano T, Minisini M. HDACs and the epigenetic plasticity of cancer cells: Target the complexity. Pharmacol Ther 2022;238:108190. [PMID: 35430294 DOI: 10.1016/j.pharmthera.2022.108190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wen Y, Zhang X, Li X, Tian L, Shen S, Ma J, Ai F. Histone deacetylase (HDAC) 11 inhibits matrix metalloproteinase (MMP) 3 expression to suppress colorectal cancer metastasis. J Cancer 2022;13:1923-32. [PMID: 35399729 DOI: 10.7150/jca.66914] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Moi D, Citarella A, Bonanni D, Pinzi L, Passarella D, Silvani A, Giannini C, Rastelli G. Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring. RSC Adv 2022;12:11548-56. [PMID: 35425078 DOI: 10.1039/d2ra01753a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Sriramareddy SN, Faião-Flores F, Emmons MF, Saha B, Chellappan S, Wyatt C, Smalley I, Licht JD, Durante MA, Harbour JW, Smalley KSM. HDAC11 activity contributes to MEK inhibitor escape in uveal melanoma. Cancer Gene Ther 2022. [PMID: 35332245 DOI: 10.1038/s41417-022-00452-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Gomez-Sanchez JA, Patel N, Martirena F, Fazal SV, Mutschler C, Cabedo H. Emerging Role of HDACs in Regeneration and Ageing in the Peripheral Nervous System: Repair Schwann Cells as Pivotal Targets. Int J Mol Sci 2022;23:2996. [PMID: 35328416 DOI: 10.3390/ijms23062996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Dai Q, Ye Y. Development and Validation of a Novel Histone Acetylation-Related Gene Signature for Predicting the Prognosis of Ovarian Cancer. Front Cell Dev Biol 2022;10:793425. [DOI: 10.3389/fcell.2022.793425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhou M, Yuan M, Zhang M, Lei C, Aras O, Zhang X, An F. Combining histone deacetylase inhibitors (HDACis) with other therapies for cancer therapy. Eur J Med Chem 2021;226:113825. [PMID: 34562854 DOI: 10.1016/j.ejmech.2021.113825] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
15 Lu J, He X, Zhang L, Zhang R, Li W. Acetylation in Tumor Immune Evasion Regulation. Front Pharmacol 2021;12:771588. [PMID: 34880761 DOI: 10.3389/fphar.2021.771588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Lin Z, Chang J, Li X, Wang J, Wu X, Liu X, Zhu Y, Yu XY. Association of DNA methylation and transcriptome reveals epigenetic etiology of heart failure. Funct Integr Genomics 2021. [PMID: 34870779 DOI: 10.1007/s10142-021-00813-9] [Reference Citation Analysis]
17 Miksiunas R, Aldonyte R, Vailionyte A, Jelinskas T, Eimont R, Stankeviciene G, Cepla V, Valiokas R, Rucinskas K, Janusauskas V, Labeit S, Bironaite D. Cardiomyogenic Differentiation Potential of Human Dilated Myocardium-Derived Mesenchymal Stem/Stromal Cells: The Impact of HDAC Inhibitor SAHA and Biomimetic Matrices. Int J Mol Sci 2021;22:12702. [PMID: 34884505 DOI: 10.3390/ijms222312702] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Dallavalle S, Musso L, Cincinelli R, Darwiche N, Gervasoni S, Vistoli G, Guglielmi MB, La Porta I, Pizzulo M, Modica E, Prosperi F, Signorino G, Colelli F, Cardile F, Fucci A, D'Andrea EL, Riccio A, Pisano C. Antitumor activity of novel POLA1-HDAC11 dual inhibitors. Eur J Med Chem 2021;:113971. [PMID: 34772529 DOI: 10.1016/j.ejmech.2021.113971] [Reference Citation Analysis]
19 Cassandri M, Pomella S, Rossetti A, Petragnano F, Milazzo L, Vulcano F, Camero S, Codenotti S, Cicchetti F, Maggio R, Festuccia C, Gravina GL, Fanzani A, Megiorni F, Catanoso M, Marchese C, Tombolini V, Locatelli F, Rota R, Marampon F. MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells. Int J Mol Sci 2021;22:10671. [PMID: 34639012 DOI: 10.3390/ijms221910671] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Zhang J, Gao X, Yu L. Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins. Front Oncol 2021;11:741746. [PMID: 34540702 DOI: 10.3389/fonc.2021.741746] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
21 Zhang X, Sun Z, Guo S, Zhang J, Gu W, Chen Z, Huang L. E3 Ubiquitin Ligase March1 Facilitates OX40L Expression in Allergen-Stimulated Dendritic Cells Through Mediating the Ubiquitination of HDAC11. J Asthma Allergy 2021;14:955-66. [PMID: 34385821 DOI: 10.2147/JAA.S318104] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Ukey S, Choudhury C, Sharma P. Identification of unique subtype-specific interaction features in Class II zinc-dependent HDAC subtype binding pockets: A computational study. J Biosci 2021;46. [DOI: 10.1007/s12038-021-00197-9] [Reference Citation Analysis]
23 Cheng F, Zheng B, Wang J, Zhao G, Yao Z, Niu Z, He W. Comprehensive analysis of a new prognosis signature based on histone deacetylases in clear cell renal cell carcinoma. Cancer Med 2021. [PMID: 34308568 DOI: 10.1002/cam4.4156] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
24 Ke X, Lin Z, Ye Z, Leng M, Chen B, Jiang C, Jiang X, Li G. Histone Deacetylases in the Pathogenesis of Diabetic Cardiomyopathy. Front Endocrinol (Lausanne) 2021;12:679655. [PMID: 34367065 DOI: 10.3389/fendo.2021.679655] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
25 Qin J, Guo N, Tong J, Wang Z. Function of histone methylation and acetylation modifiers in cardiac hypertrophy. J Mol Cell Cardiol 2021;159:120-9. [PMID: 34175302 DOI: 10.1016/j.yjmcc.2021.06.011] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
26 Cheng F, Zheng B, Wang J, Zhao G, Yao Z, Niu Z, He W. Histone deacetylase 10, a potential epigenetic target for therapy. Biosci Rep 2021;41:BSR20210462. [PMID: 33997894 DOI: 10.1042/BSR20210462] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
27 Fang Z, Wang X, Sun X, Hu W, Miao QR. The Role of Histone Protein Acetylation in Regulating Endothelial Function. Front Cell Dev Biol 2021;9:672447. [PMID: 33996829 DOI: 10.3389/fcell.2021.672447] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Núñez-Álvarez Y, Suelves M. HDAC11: a multifaceted histone deacetylase with proficient fatty deacylase activity and its roles in physiological processes. FEBS J 2021. [PMID: 33891374 DOI: 10.1111/febs.15895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
29 Lodewijk I, Nunes SP, Henrique R, Jerónimo C, Dueñas M, Paramio JM. Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy. Clin Epigenetics 2021;13:63. [PMID: 33761971 DOI: 10.1186/s13148-021-01046-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
30 Rahmani G, Sameri S, Abbasi N, Abdi M, Najafi R. The clinical significance of histone deacetylase-8 in human breast cancer. Pathol Res Pract 2021;220:153396. [PMID: 33691240 DOI: 10.1016/j.prp.2021.153396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
31 Ružić D, Đoković N, Nikolić K, Vujić Z. Medicinal chemistry of histone deacetylase inhibitors. Arhiv za farmaciju 2021;71:73-100. [DOI: 10.5937/arhfarm71-30618] [Cited by in F6Publishing: 1] [Reference Citation Analysis]